In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method
- 1 August 2002
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 43 (4) , 319-321
- https://doi.org/10.1016/s0732-8893(02)00407-8
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Oxazolidinone antibioticsThe Lancet, 2001
- Evaluation of Current Methods for Detection of Staphylococci with Reduced Susceptibility to GlycopeptidesJournal of Clinical Microbiology, 2001
- In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococciClinical Microbiology & Infection, 2000
- In vitro activity of linezolid against staphylococciClinical Microbiology & Infection, 2000
- Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfopristin, Gentamicin, and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureus StrainsAntimicrobial Agents and Chemotherapy, 1999
- Multidrug Resistance — A Sign of the TimesNew England Journal of Medicine, 1998
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Susceptibility of staphylococci and enterococci to glycopeptides comparison of 3 test methods*Zentralblatt für Bakteriologie, 1995
- Optimizing testing of methicillin-resistant Staphylococcus speciesDiagnostic Microbiology and Infectious Disease, 1994
- The E-Test applied to susceptibility tests of gonococci, multiply-resistant enterococci, and enterobacteriaceae producing potent β-lactamasesDiagnostic Microbiology and Infectious Disease, 1992